OP0041 Pregnancy Outcomes for Systemic Lupus Erythematosus (SLE) Subjects with Conception during Belimumab Intravenous (IV) and Subcutaneous (SC) Placebo-Controlled Clinical Trials and Long Term Extension Trials
Publication
, Conference
Powell, M; Hill, D; Eudy, A; Landy, H; Petri, M
Published in: Annals of the Rheumatic Diseases
June 2014
Duke Scholars
Published In
Annals of the Rheumatic Diseases
DOI
EISSN
1468-2060
ISSN
0003-4967
Publication Date
June 2014
Volume
73
Issue
Suppl 2
Start / End Page
75.3 / 76
Publisher
BMJ
Related Subject Headings
- Arthritis & Rheumatology
- 3204 Immunology
- 3202 Clinical sciences
- 1117 Public Health and Health Services
- 1107 Immunology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Powell, M., Hill, D., Eudy, A., Landy, H., & Petri, M. (2014). OP0041 Pregnancy Outcomes for Systemic Lupus Erythematosus (SLE) Subjects with Conception during Belimumab Intravenous (IV) and Subcutaneous (SC) Placebo-Controlled Clinical Trials and Long Term Extension Trials. In Annals of the Rheumatic Diseases (Vol. 73, pp. 75.3-76). BMJ. https://doi.org/10.1136/annrheumdis-2014-eular.4484
Powell, M., D. Hill, A. Eudy, H. Landy, and M. Petri. “OP0041 Pregnancy Outcomes for Systemic Lupus Erythematosus (SLE) Subjects with Conception during Belimumab Intravenous (IV) and Subcutaneous (SC) Placebo-Controlled Clinical Trials and Long Term Extension Trials.” In Annals of the Rheumatic Diseases, 73:75.3-76. BMJ, 2014. https://doi.org/10.1136/annrheumdis-2014-eular.4484.
Powell M, Hill D, Eudy A, Landy H, Petri M. OP0041 Pregnancy Outcomes for Systemic Lupus Erythematosus (SLE) Subjects with Conception during Belimumab Intravenous (IV) and Subcutaneous (SC) Placebo-Controlled Clinical Trials and Long Term Extension Trials. In: Annals of the Rheumatic Diseases. BMJ; 2014. p. 75.3-76.
Powell, M., et al. “OP0041 Pregnancy Outcomes for Systemic Lupus Erythematosus (SLE) Subjects with Conception during Belimumab Intravenous (IV) and Subcutaneous (SC) Placebo-Controlled Clinical Trials and Long Term Extension Trials.” Annals of the Rheumatic Diseases, vol. 73, no. Suppl 2, BMJ, 2014, pp. 75.3-76. Crossref, doi:10.1136/annrheumdis-2014-eular.4484.
Powell M, Hill D, Eudy A, Landy H, Petri M. OP0041 Pregnancy Outcomes for Systemic Lupus Erythematosus (SLE) Subjects with Conception during Belimumab Intravenous (IV) and Subcutaneous (SC) Placebo-Controlled Clinical Trials and Long Term Extension Trials. Annals of the Rheumatic Diseases. BMJ; 2014. p. 75.3-76.
Published In
Annals of the Rheumatic Diseases
DOI
EISSN
1468-2060
ISSN
0003-4967
Publication Date
June 2014
Volume
73
Issue
Suppl 2
Start / End Page
75.3 / 76
Publisher
BMJ
Related Subject Headings
- Arthritis & Rheumatology
- 3204 Immunology
- 3202 Clinical sciences
- 1117 Public Health and Health Services
- 1107 Immunology
- 1103 Clinical Sciences